Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR 1,946.95
-37.55 (-1.89%)
At close: Feb 13, 2026
Metropolis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 15,665 | 13,312 | 12,077 | 11,482 | 12,283 | 9,980 |
Revenue Growth (YoY) | 18.95% | 10.22% | 5.18% | -6.52% | 23.08% | 16.53% |
Cost of Revenue | 3,518 | 3,030 | 2,699 | 2,741 | 2,976 | 2,702 |
Gross Profit | 12,146 | 10,282 | 9,378 | 8,742 | 9,307 | 7,278 |
Selling, General & Admin | 5,302 | 4,798 | 4,138 | 3,730 | 3,649 | 2,746 |
Research & Development | 207.55 | 102 | 135.77 | 65.71 | 69.07 | 54.46 |
Other Operating Expenses | 3,072 | 2,339 | 2,209 | 2,017 | 2,140 | 1,594 |
Operating Expenses | 9,819 | 8,326 | 7,427 | 6,704 | 6,491 | 4,854 |
Operating Income | 2,327 | 1,956 | 1,951 | 2,037 | 2,817 | 2,423 |
Interest Expense | -212.09 | -185.75 | -225.36 | -268.01 | -197.42 | -77.82 |
Interest & Investment Income | 58.48 | 58.48 | 69.1 | 102.3 | 111.48 | 93.01 |
Currency Exchange Gain (Loss) | -13.22 | -13.22 | -59.57 | -1.84 | -6.11 | -22.77 |
Other Non Operating Income (Expenses) | 92.81 | - | - | -0 | 48.02 | 20.1 |
EBT Excluding Unusual Items | 2,253 | 1,816 | 1,735 | 1,870 | 2,773 | 2,436 |
Impairment of Goodwill | - | - | - | - | -1.88 | - |
Gain (Loss) on Sale of Investments | 75.06 | 75.06 | 11.56 | 6.78 | 4.26 | 7.33 |
Gain (Loss) on Sale of Assets | 17.59 | 17.59 | - | 0.08 | -0.16 | -0.11 |
Asset Writedown | - | - | - | -1.35 | -0.34 | - |
Other Unusual Items | -90.97 | - | - | - | 159.02 | - |
Pretax Income | 2,255 | 1,909 | 1,747 | 1,875 | 2,934 | 2,443 |
Income Tax Expense | 560.04 | 453.39 | 462.33 | 441.09 | 786.65 | 609.74 |
Earnings From Continuing Operations | 1,695 | 1,455 | 1,285 | 1,434 | 2,147 | 1,833 |
Minority Interest in Earnings | -11.98 | -5.46 | -6.39 | -5.11 | -5.04 | -2.54 |
Net Income | 1,683 | 1,450 | 1,278 | 1,429 | 2,142 | 1,831 |
Net Income to Common | 1,683 | 1,450 | 1,278 | 1,429 | 2,142 | 1,831 |
Net Income Growth | 10.53% | 13.42% | -10.54% | -33.29% | 16.98% | 43.80% |
Shares Outstanding (Basic) | 52 | 51 | 51 | 51 | 51 | 51 |
Shares Outstanding (Diluted) | 52 | 51 | 51 | 51 | 51 | 51 |
Shares Change (YoY) | 0.90% | 0.19% | 0.05% | -0.09% | 0.49% | 1.44% |
EPS (Basic) | 32.56 | 28.29 | 24.95 | 27.91 | 41.87 | 35.97 |
EPS (Diluted) | 32.39 | 28.15 | 24.87 | 27.81 | 41.66 | 35.79 |
EPS Growth | 9.53% | 13.19% | -10.57% | -33.25% | 16.40% | 41.74% |
Free Cash Flow | - | 2,193 | 2,003 | 1,945 | 2,226 | 2,208 |
Free Cash Flow Per Share | - | 42.60 | 38.98 | 37.85 | 43.30 | 43.15 |
Dividend Per Share | - | - | 4.000 | 8.000 | 8.000 | 8.000 |
Dividend Growth | - | - | -50.00% | - | - | - |
Gross Margin | 77.54% | 77.24% | 77.65% | 76.13% | 75.77% | 72.92% |
Operating Margin | 14.85% | 14.70% | 16.16% | 17.74% | 22.93% | 24.28% |
Profit Margin | 10.74% | 10.89% | 10.58% | 12.44% | 17.44% | 18.35% |
Free Cash Flow Margin | - | 16.48% | 16.59% | 16.94% | 18.12% | 22.12% |
EBITDA | 2,516 | 2,161 | 2,176 | 2,356 | 3,067 | 2,633 |
EBITDA Margin | 16.06% | 16.23% | 18.02% | 20.52% | 24.97% | 26.38% |
D&A For EBITDA | 188.83 | 204.24 | 224.79 | 318.6 | 250.63 | 209.61 |
EBIT | 2,327 | 1,956 | 1,951 | 2,037 | 2,817 | 2,423 |
EBIT Margin | 14.85% | 14.70% | 16.16% | 17.74% | 22.93% | 24.28% |
Effective Tax Rate | 24.84% | 23.76% | 26.47% | 23.52% | 26.82% | 24.96% |
Revenue as Reported | 15,908 | 13,463 | 12,168 | 11,634 | 12,460 | 10,100 |
Advertising Expenses | - | 379.48 | 327.74 | 261.56 | 260.32 | 131.25 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.